Authored by James Sheppard The global generics giant Actavis has announced a deal to acquire the Chicago based infectious disease specialist Durata Therapeutics. The deal is estimated to be worth in excess of $675m. The deal will see Actavis paying … Continue reading
The post Actavis bolsters infectious disease portfolio with Durata purchase appeared first on Liftstream.
